Doggrell S A, Liang L C
Department of Pharmacology and Clinical Pharmacology, School of Medicine, The University of Auckland, New Zealand.
Naunyn Schmiedebergs Arch Pharmacol. 1998 Feb;357(2):126-32. doi: 10.1007/pl00005146.
BDF 9148, a positive cardiac inotrope, relaxes the rat isolated portal vein and the KCl-contracted rat aorta. The aims of our study were to determine the mechanism of action of BDF 9148, and to ascertain whether the relaxing effect of BDF 9148 was maintained in the presence of the hypertrophy associated with hypertension, by investigating the effects of BDF 9148 on the contractility and electrophysiology of aortae of Wistar Kyoto normo-tensive rats (WKY) and Spontaneously Hypertensive Rats (SHRs). High concentrations of veratridine contracted the quiescent rat aorta. BDF 9148 had no effect on the quiescent, but relaxed the KCl-contracted WKY and SHR aorta by a tetrodotoxin insensitive mechanism, and these relaxations decreased with age but were not greatly altered by hypertrophy. The verapamil relaxations of the KCl-contracted aorta were not altered by age or hypertrophy. The ability of KCl to depolarise the aorta was reversed by verapamil, but not by BDF 9148. On the contracted rat aorta, the relaxant responses to acetylcholine were abolished by removal of the endothelium but potentiated by IBMX (10[-6] M), and the responses to isoprenaline were inhibited by propranolol (10[-6] M) but potentiated by forskolin (10[-7] M). The relaxation responses of the KCl-contracted aorta to BDF 9148 were not altered by removal of the endothelium, or by propranolol, forskolin and IBMX. In summary, the effects of verapamil and BDF 9148 on the aorta are different, and thus it is unlikely that the relaxant responses to BDF 9148 on the aorta are due to calcium channel blocking activity. The mechanism of the relaxant effect of BDF 9148 on the aorta remains unknown, but we have shown the response is endothelium-independent, and not mediated by sodium channel opening, hyperpolarization, beta-adrenoceptors, or by stimulating adenylate cyclase or guanylate cyclase.
BDF 9148是一种正性心肌变力剂,可使大鼠离体门静脉和氯化钾收缩的大鼠主动脉舒张。我们研究的目的是确定BDF 9148的作用机制,并通过研究BDF 9148对Wistar Kyoto正常血压大鼠(WKY)和自发性高血压大鼠(SHR)主动脉收缩性和电生理学的影响,来确定在与高血压相关的肥大情况下BDF 9148的舒张作用是否得以维持。高浓度的藜芦定使静息状态的大鼠主动脉收缩。BDF 9148对静息状态的主动脉无作用,但通过一种对河豚毒素不敏感的机制使氯化钾收缩的WKY和SHR主动脉舒张,这些舒张作用随年龄增长而减弱,但不受肥大的显著影响。维拉帕米对氯化钾收缩的主动脉的舒张作用不受年龄或肥大的影响。维拉帕米可逆转氯化钾使主动脉去极化的作用,但BDF 9148不能。在收缩的大鼠主动脉上,去除内皮可消除对乙酰胆碱的舒张反应,但IBMX(10[-6] M)可增强该反应,对异丙肾上腺素的反应可被普萘洛尔(10[-6] M)抑制,但可被福斯高林(10[-7] M)增强。去除内皮、普萘洛尔、福斯高林和IBMX均不改变氯化钾收缩的主动脉对BDF 9148的舒张反应。总之,维拉帕米和BDF 9148对主动脉的作用不同,因此BDF 9148对主动脉的舒张反应不太可能是由于钙通道阻滞活性。BDF 9148对主动脉舒张作用的机制尚不清楚,但我们已表明该反应不依赖于内皮,也不是由钠通道开放、超极化、β-肾上腺素能受体或刺激腺苷酸环化酶或鸟苷酸环化酶介导的。